![تويتر \ Sherman Prize على تويتر: "Dr Jean-Frederic Colombel of @IcahnMountSinai @MountSinaiNYC wins 2018 Sherman Prize for his research in #IBD genetics, risk factors & treatment. We're looking forward to honoring him تويتر \ Sherman Prize على تويتر: "Dr Jean-Frederic Colombel of @IcahnMountSinai @MountSinaiNYC wins 2018 Sherman Prize for his research in #IBD genetics, risk factors & treatment. We're looking forward to honoring him](https://pbs.twimg.com/media/DtR5L7FXoAEP_73.jpg)
تويتر \ Sherman Prize على تويتر: "Dr Jean-Frederic Colombel of @IcahnMountSinai @MountSinaiNYC wins 2018 Sherman Prize for his research in #IBD genetics, risk factors & treatment. We're looking forward to honoring him
![ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well](https://medicalupdateonline.com/wp-content/uploads/2016/05/ECCO-2016-Part-1-Update-from-GEMINI-Study.jpg)
ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well
Sherman Prize - Congratulations Dr. Jean-Frederic Colombel of Mount Sinai who receives the $100K Sherman Prize for leading breakthroughs in understanding IBD genetics, risk factors and optimal treatment approaches. Read more https://bit.ly/2O9Blab
![Mount Sinai Health System on Twitter: "Congratulations to Dr. Jean-Frederic Colombel for being awarded as one of the 2018 @ShermanPrize Recipients: https://t.co/9E2W99TOPU #ShermanPrize https://t.co/660uLRkuq6" / Twitter Mount Sinai Health System on Twitter: "Congratulations to Dr. Jean-Frederic Colombel for being awarded as one of the 2018 @ShermanPrize Recipients: https://t.co/9E2W99TOPU #ShermanPrize https://t.co/660uLRkuq6" / Twitter](https://pbs.twimg.com/media/DvNUA7bWsAAXOQ5.jpg)
Mount Sinai Health System on Twitter: "Congratulations to Dr. Jean-Frederic Colombel for being awarded as one of the 2018 @ShermanPrize Recipients: https://t.co/9E2W99TOPU #ShermanPrize https://t.co/660uLRkuq6" / Twitter
![1356783989 NPI Number | JEAN-FREDERIC COLOMBEL M.D. | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023 1356783989 NPI Number | JEAN-FREDERIC COLOMBEL M.D. | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023](https://www.hipaaspace.com/medical_billing/coding/national_provider_identifier/codes/npi_1356783989.png)
1356783989 NPI Number | JEAN-FREDERIC COLOMBEL M.D. | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023
![Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY](https://www.touchimmunology.com/wp-content/uploads/sites/18/2022/02/TMM-IMMUNOLOGY-Jean-Frederic-Colombel-thumbnail.jpg)
Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY
AGA Clinical Practice Update: Functional gastrointestinal symptoms in patients with inflammatory bowel disease | GI and Hepatology News
![Join Jean-Frederic Colombel, MD and his team for "Mount Sinai IBD Course for Ukraine" - Physician's Channel - Mount Sinai New York Join Jean-Frederic Colombel, MD and his team for "Mount Sinai IBD Course for Ukraine" - Physician's Channel - Mount Sinai New York](http://55933-bcmed.s3.amazonaws.com/bcp/images/dmImage/SourceImage/gastro-event---carousel-image2.png)
Join Jean-Frederic Colombel, MD and his team for "Mount Sinai IBD Course for Ukraine" - Physician's Channel - Mount Sinai New York
![Jean-Frederic Colombel, ECCO 2023: LIBERTY-CD: subcutaneous infliximab as Crohn's disease maintenance therapy - touchIMMUNOLOGY Jean-Frederic Colombel, ECCO 2023: LIBERTY-CD: subcutaneous infliximab as Crohn's disease maintenance therapy - touchIMMUNOLOGY](https://www.touchimmunology.com/wp-content/uploads/sites/18/2023/02/TMM-IMMUNO-Jean-Frederic-Colombel-thumbnail.jpg)